CFM
Catalyst Funds Management Portfolio holdings
AUM
$362M
1-Year Return
42.71%
This Quarter Return
+7.61%
1 Year Return
+42.71%
3 Year Return
–
5 Year Return
–
10 Year Return
–
AUM
$373M
AUM Growth
+$14.7M
(+4.1%)
Cap. Flow
+$16.4M
Cap. Flow
% of AUM
4.4%
Top 10 Holdings %
Top 10 Hldgs %
46.87%
Holding
1,707
New
616
Increased
178
Reduced
304
Closed
565
Top Buys
| 1 |
Apple
AAPL
|
+$61.8M |
| 2 |
3M
MMM
|
+$18.6M |
| 3 |
Nu Holdings
NU
|
+$15.9M |
| 4 |
Broadcom
AVGO
|
+$14.2M |
| 5 |
Spotify
SPOT
|
+$12.3M |
Top Sells
| 1 |
Walmart
WMT
|
+$10.9M |
| 2 |
Kenvue
KVUE
|
+$7.2M |
| 3 |
Newmont
NEM
|
+$6M |
| 4 |
WBA
Walgreens Boots Alliance
WBA
|
+$5.92M |
| 5 |
Meta Platforms (Facebook)
META
|
+$5.55M |
Sector Composition
| 1 | Technology | 33.66% |
| 2 | Industrials | 12.6% |
| 3 | Financials | 12.32% |
| 4 | Communication Services | 12.12% |
| 5 | Consumer Discretionary | 6.04% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1076
Wabash National
WNC
$461M
| $4.37K | ﹤0.01% |
200
-400
| -67% | -$8.74K |
|
|
ZH
1077
Zhihu
ZH
$449M
| $4.37K | ﹤0.01% |
+1,600
| New | +$4.37K |
|
1078
Urban One Class D
UONEK
$37.7M
| $4.35K | ﹤0.01% |
+2,900
| New | +$4.35K |
|
1079
Zevia
ZVIA
$184M
| $4.32K | ﹤0.01% |
+6,400
| New | +$4.32K |
|
1080
BayCom
BCML
$329M
| $4.07K | ﹤0.01% |
200
| – | – |
|
1081
Ginkgo Bioworks
DNA
$609M
| $4.01K | ﹤0.01% |
+300
| New | +$4.01K |
|
|
WSR
1082
Whitestone REIT
WSR
$656M
| $3.99K | ﹤0.01% |
300
+200
| +200% | +$2.66K |
|
1083
Treace Medical Concepts
TMCI
$442M
| $3.99K | ﹤0.01% |
600
+500
| +500% | +$3.33K |
|
|
ZUO
1084
DELISTED
Zuora, Inc.
ZUO
| $3.97K | ﹤0.01% |
+400
| New | +$3.97K |
|
|
TWO
1085
Two Harbors Investment
TWO
$1.06B
| $3.96K | ﹤0.01% |
+300
| New | +$3.96K |
|
1086
PRA Group
PRAA
$653M
| $3.93K | ﹤0.01% |
+200
| New | +$3.93K |
|
|
ARR
1087
Armour Residential REIT
ARR
$1.74B
| $3.88K | ﹤0.01% |
200
+100
| +100% | +$1.94K |
|
1088
Sprinklr
CXM
$1.88B
| $3.85K | ﹤0.01% |
+400
| New | +$3.85K |
|
1089
Liberty Latin America Class C
LILAK
$1.54B
| $3.85K | ﹤0.01% |
400
-1,100
| -73% | -$10.6K |
|
|
RCM
1090
DELISTED
R1 RCM Inc. Common Stock
RCM
| $3.77K | ﹤0.01% |
+300
| New | +$3.77K |
|
1091
RPC Inc
RES
$1.02B
| $3.75K | ﹤0.01% |
+600
| New | +$3.75K |
|
1092
Hayward Holdings
HAYW
$3.4B
| $3.69K | ﹤0.01% |
300
+100
| +50% | +$1.23K |
|
1093
BRF SA
BRFS
$5.99B
| $3.66K | ﹤0.01% |
+900
| New | +$3.66K |
|
1094
Privia Health
PRVA
$2.78B
| $3.48K | ﹤0.01% |
200
-9,000
| -98% | -$156K |
|
1095
Mersana Therapeutics
MRSN
$36.7M
| $3.42K | ﹤0.01% |
+68
| New | +$3.42K |
|
1096
PMV Pharmaceuticals
PMVP
$67.3M
| $3.4K | ﹤0.01% |
+2,100
| New | +$3.4K |
|
1097
S&T Bancorp
STBA
$1.49B
| $3.34K | ﹤0.01% |
100
-3,100
| -97% | -$104K |
|
1098
QuinStreet
QNST
$912M
| $3.32K | ﹤0.01% |
+200
| New | +$3.32K |
|
1099
Central Garden & Pet Class A
CENTA
$2.07B
| $3.3K | ﹤0.01% |
100
-300
| -75% | -$9.91K |
|
1100
Adaptive Biotechnologies
ADPT
$1.89B
| $3.26K | ﹤0.01% |
+900
| New | +$3.26K |
|